Clinical Trial Update: Continuation Treatment Protocol for Patient Who Participated in the BIA 9-1067-302 Clinical Trial [Phase 3]

View source ↗

Summary

A continuation treatment protocol update for a participant in the Phase 3 BIA 9-1067-302 clinical trial.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• BIA 9-1067-302

Snippet

Sponsor: Rabin Medical Center | Conditions: Parkinson Disease | Phase 3 | Status: COMPLETED